Additionally, more significant tumor sizes and lower OS rates were linked to higher plasma IGFBP-2 levels, demonstrating that IGFBP-2 may function as a prognostic and diagnostic biomarker for CRC. The gene discussed is IGFBP2; the disease is colorectal carcinoma.